Allegations of Waste: The 'Seeding' Study

See allHide authors and affiliations

Science  10 Oct 2008:
Vol. 322, Issue 5899, pp. 213
DOI: 10.1126/science.322.5899.213

You are currently viewing the summary.

View Full Text


Internal company documents suggesting that a 1999 trial of the Merck painkiller Vioxx had more to do marketing than with science have focused new attention on so-called seeding trials aimed at promoting new treatments.